Skip to content

Clinical trials

Terminated Multiple Sclerosis, Relapsing-Remitting trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Status: Terminated Country / region: Belgium Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20131
20141
20151
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen1
Boston Scientific Corporation1
Hoffmann-La Roche1
Imcyse SA1
Novartis Pharmaceuticals1
University Hospital of Mont-Godinne1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting6
Multiple Sclerosis3
Demyelinating Diseases2
Nervous System Diseases2
Autoimmune Diseases1
Brain Diseases1
Camurati-Engelmann Syndrome1
Central Nervous System Diseases1
Cognition Disorders1
Fatigue1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.